comparemela.com

Luc Van Rompaey News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Irish fund Fountain Healthcare leads €40m Dualyx fundraise

Belgian company hopes to break new ground in autoimmune disease treatments

New yorkUnited statesBioequity europeLuc van rompaeyWouter verhoevenBernard coulieBarry connollyFountain healthcare partnersBelgium based dualysAndera partnersEna prosserYear barry connollyPliant therapeuticsParis based andera partners

Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic

Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic Use of proceeds will enable the development of the Company's lead autoimmune program DT-001, targeting

France generalNew yorkUnited statesBernard coulieLucy featherstoneAneta sottilJuliette audetLuc van rompaeyAndera croissanceWouter verhoevenBandera coGhent universityConsilium strategic communicationsWurzburg universityAndera life sciencesFountain healthcare partners

EQS-News: Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases

EQS-News: Andera Partners / Key word(s): Financing Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases 15.05.2023

France generalRegion flamandeAndera croissanceAneta sottilBernard coulieWouter verhoevenLuc van rompaeyAndera life sciencesWurzburg universityMc servicesDistribution servicesGhent universityBandera coAndera partnersFountain healthcare partnersIndependent chairman

Dualyx Raises €40M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Region flamandeWouter verhoevenAneta sottilLuc van rompaeyGhent universityWurzburg universityFountain healthcare partnersV bio venturesAndera partnersDualyx board

vimarsana © 2020. All Rights Reserved.